Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. PT Asuransi Bina Dana Arta Tbk's accounts receivables for the quarter that ended in Jun. 2026 was Rp0 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
PT Asuransi Bina Dana Arta Tbk's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 0.00.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. PT Asuransi Bina Dana Arta Tbk's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was Rp1,804.21.
PT Asuransi Bina Dana Arta Tbk Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
PT Asuransi Bina Dana Arta Tbk's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), PT Asuransi Bina Dana Arta Tbk's accounts receivable are only considered to be worth 75% of book value:
PT Asuransi Bina Dana Arta Tbk's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
PT Asuransi Bina Dana Arta Tbk Accounts Receivable Related Terms
PT Asuransi Bina Dana Arta Tbk Accounts Receivable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Asuransi Bina Dana Arta Tbk Accounts Receivable Chart
PT Asuransi Bina Dana Arta Tbk (ISX:ABDA) has a Accounts Receivable of Rp0 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on PT Asuransi Bina Dana Arta Tbk and its competitors.
Is PT Asuransi Bina Dana Arta Tbk's Accounts Receivable too high?
PT Asuransi Bina Dana Arta Tbk's current Accounts Receivable is Rp0 Mil. Overall, PT Asuransi Bina Dana Arta Tbk has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Asuransi Bina Dana Arta Tbk's Accounts Receivable compare to CB and PGR?
PT Asuransi Bina Dana Arta Tbk's Accounts Receivable of Rp0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for an Insurance company?
A good Accounts Receivable depends on the Insurance industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on PT Asuransi Bina Dana Arta Tbk and its competitors. PT Asuransi Bina Dana Arta Tbk's current Accounts Receivable is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Asuransi Bina Dana Arta Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Asuransi Bina Dana Arta Tbk (ISX:ABDA) is currently considered Fairly Valued. The stock's GF Value™ is Rp4,522.39, compared to a current price of Rp4,970.00 — trading 9.9% above its estimated fair value. The current Accounts Receivable is Rp0 Mil. PT Asuransi Bina Dana Arta Tbk's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For PT Asuransi Bina Dana Arta Tbk (ISX:ABDA), the current Accounts Receivable is Rp0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Asuransi Bina Dana Arta Tbk (ISX:ABDA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Asuransi Bina Dana Arta Tbk stock appears to be overvalued.
The current stock price of Rp4,970.00 is trading 9.9% above its estimated GF Value™ of Rp4,522.39.
GuruFocus considers PT Asuransi Bina Dana Arta Tbk to be Fairly Valued.
Key valuation signals for ISX:ABDA:
Accounts Receivable: Rp0 Mil
GF Value™: Rp4,522.39 vs. price of Rp4,970.00 (9.9% above fair value)
No single metric tells the full story. See the ISX:ABDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Asuransi Bina Dana Arta Tbk is an Indonesian-based insurance service provider. It provides insurance services protection against any losses, such as fire, vehicles, engineering, liability, transportation, heavy equipment and machinery, health protection, and others. The company generates the majority of the premium revenue from the Motor vehicle insurance services it provides. Geographically, the group operations in Indonesia are carried out in Sumatra and Batam, Kalimantan, Jawa, Sulawesi, Bali, and Greater Jakarta, of which key revenue is derived from Greater Jakarta.
48GF Score
Get the complete analysis for ISX:ABDA
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:ABDA has been successfully added to your 
